ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
ARISE III Trial of Gore Ascending Stent Graft Begins Enrollment
Thursday, January 15, 2026
Submitted by
Source
Source Name: Endovascular Today
The first patient implantation of the investigational Gore Ascending Stent Graft in the ARISE III trial for treating acute type A dissections in high-risk surgical patients has been announced. The trial will enroll up to 112 patients across multiple US centers, with follow-up assessments over five years to evaluate safety and effectiveness.
Printer-friendlyShare
